Hepion Pharmaceuticals director James Gordon Liddy files initial beneficial ownership statement
HEPA•Director files initial Form 3
- Hepion Pharmaceuticals director James Gordon Liddy filed an initial Form 3 on Aug. 21, dated Aug. 19.
HEPA•HEPA•HEPA•
